DUBLIN–(BUSINESS WIRE)–The “Global Lignocaine Market 2021-2027” report has been added to ResearchAndMarkets.com’s offering.
The global lignocaine market is anticipated to grow at a considerable CAGR during the forecast period. The increase in the number of surgical operations including dental procedures, aesthetic surgery, and plastic surgeries across the globe has created demand for lignocaine to alleviate post-operative pain, thereby driving the market growth.
The rise in chronic and acute pain problems throughout the world, as well as the economical advantages connected with lignocaine hydrochloride, are some of the key reasons driving the market growth.
The global lignocaine market is segmented based on dosage form and application. Based on dosage form, the market is sub-segmented into creams, patches, injectables, others. On the basis of application, the market is sub-segmented into heart arrhythmia, dental procedure, epilepsy, and others.
Geographically, the global lignocaine market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.
Some of the companies operating in the global lignocaine market include Alanza Inc., Amphastar Pharmaceuticals, Inc., Cirondrugs, Mahendra Chemicals, and Pfizer Inc. among others.
Market Segmentation
- Global Lignocaine Market Research and Analysis by Dosage Form
- Global Lignocaine Market Research and Analysis by Application
The Report Covers
- Comprehensive research methodology of the global lignocaine market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global Lignocaine market.
- Insights about market determinants that are stimulating the global lignocaine market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Lignocaine Market by Dosage Form
4.1.1. Creams
4.1.2. Patches
4.1.3. Injectables
4.1.4. Others
4.2. Global Lignocaine Market by Application
4.2.1. Heart Arrhythmia
4.2.2. Dental Procedure
4.2.3. Epilepsy
4.2.4. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Alanza Inc.
6.2. Amphastar Pharmaceuticals, Inc.
6.3. Cirondrugs
6.4. Mahendra Chemicals
6.5. Pfizer Inc.
For more information about this report visit https://www.researchandmarkets.com/r/nedxgo
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
